Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank86
3Y CAGR+27.7%
5Y CAGR+5.9%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+27.7%/yr
Annual compound
5Y CAGR
+5.9%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 22.76 | -97.2% |
| 2024 | 800.84 | +45237.9% |
| 2023 | -1.77 | -116.2% |
| 2022 | 10.93 | +205.2% |
| 2021 | 3.58 | -79.1% |
| 2020 | 17.10 | -82.3% |
| 2019 | 96.57 | +1824.4% |
| 2018 | -5.60 | +70.6% |
| 2017 | -19.03 | +29.8% |
| 2016 | -27.12 | - |